Camiel JF Boon
Amsterdam UMC · Leiden University Medical Center · Leiden University Medical Center & Radboud University Nijmegen Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Camiel JF Boon as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06114537 · The AXIS Study: the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in RetinoschisisAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · completed · Retinoschisis · principal investigator
- Ph4NCT03079141 · Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous ChorioretinopathyLeiden University Medical Center · unknown · Chronic Central Serous Chorioretinopathy · principal investigator
- Ph4NCT01797861 · Prospective Randomized Controlled Treatment Trial for Chronic Central Serous ChorioretinopathyRadboud University Medical Center · completed · Chronic Central Serous Chorioretinopathy · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:55 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.Ophthalmology · 2018306 citationsRCR 20.6
- OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.Invest Ophthalmol Vis Sci · 2015132 citationsRCR 7.7
- Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.Am J Ophthalmol · 202290 citationsRCR 12.2
- Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging.Invest Ophthalmol Vis Sci · 201159 citationsRCR 2.1
- Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.Am J Ophthalmol · 201954 citationsRCR 4.4
- Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.Am J Ophthalmol · 202047 citationsRCR 4.2
- 46 citationsRCR 2.6
- Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.Acta Ophthalmol · 202136 citationsRCR 3.9
- Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.Acta Ophthalmol · 201625 citationsRCR 1.8
- Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol · 202023 citationsRCR 2.3